Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), sold 135,414 shares at $38.36 ($5.2M) on 2025-12-15, disclosed to the SEC on 2025-12-17.
Scheduled sale ($5.2M) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.36 | 3,750 | $144K | 2.8% |
| 2 | $38.36 | 65,832 | $2.5M | 48.6% |
| 3 | $38.36 | 65,832 | $2.5M | 48.6% |
| Total | $38.36 avg | 135,414 | $5.2M | 100% |
| Filing → |
| RPRX | SELL | 2026-04-30 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-25 | $3.2M | — | Filing → |